BridgeBio Pharma (BBIO) Prepaid Assets (2018 - 2026)

BridgeBio Pharma (BBIO) has 9 years of Prepaid Assets data on file, last reported at $62.9 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets rose 77.95% year-over-year to $62.9 million; the trailing twelve-month figure through Mar 2026 stood at $62.9 million (up 77.95% YoY), and the FY2025 full-year result was $44.1 million, up 26.39% from the prior year.
• Prepaid Assets grew to $62.9 million in Q1 2026, from $44.1 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $62.9 million in Q1 2026 to a low of $20.5 million in Q2 2023.
• A 5-year average of $34.8 million and a median of $32.8 million in 2022 frame the typical range for Prepaid Assets.
• Across the five-year window, Prepaid Assets plunged 37.27% in 2023 and surged 112.14% in 2025, its largest moves.
• Tracing BBIO's Prepaid Assets over 5 years: stood at $21.9 million in 2022, then climbed by 10.87% to $24.3 million in 2023, then soared by 43.46% to $34.9 million in 2024, then gained by 26.39% to $44.1 million in 2025, then soared by 42.76% to $62.9 million in 2026.
• Business Quant data shows BBIO's Prepaid Assets at $62.9 million in Q1 2026, $44.1 million in Q4 2025, and $52.4 million in Q3 2025.